Breast Cancer Trial, Not Yet Recruiting NCT07292727 Sponsor: Cairo University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07292727
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with breast cancer.
  • People who are experiencing pain.
  • People who are experiencing anxiety.
  • People who have completed at least one cycle (session) of chemotherapy.
  • People who are receiving the same type of chemotherapy as other participants in the trial.
  • People who did not have an anxiety disorder before starting chemotherapy.
  • People who are going through chemotherapy for the first time as part of their treatment.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have injuries to the face or head.
  • People who have injuries to the hands.
  • People who have difficulties with thinking, memory, or understanding (cognitive impairment).
  • People who have a history of severe motion sickness.
  • People who have mental health problems.
  • People who have problems with their vision or hearing.
  • People who are receiving radiotherapy.
  • People who have a history of structural differences in the skull or neck area that may make wearing a virtual reality (VR) headset difficult or unsafe (confirm with trial site).
  • People who have a history of epilepsy, seizures, or vertigo.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ahmed Khalifa, Professor, Sohag University

Phone: 20 11 57332708

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
15 March 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Assessment of pain intensity; Assessment of anxiety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov